NCT03780504View on ClinicalTrials.gov

Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in Greece

UnknownOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

July 20, 2021

Study Completion Date

December 31, 2022

Conditions
Psoriatic Arthritis
Trial Locations (1)

Unknown

Euromedica Private Clinic, Thessaloniki

Sponsors

Collaborators (2)

Celgene
Amgen
All Listed Sponsors
collaborator

Celgene

INDUSTRY

collaborator

Amgen

INDUSTRY

lead

Genesis Pharma S.A.

INDUSTRY

NCT03780504 - Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in Greece | Biotech Hunter | Biotech Hunter